Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001015820-16-000045
Filing Date
2016-01-11
Accepted
2016-01-11 07:46:27
Documents
3
Period of Report
2016-01-31

Document Format Files

Seq Description Document Type Size
1 6-K jan2016pr.htm 6-K 65909
2 qgennewheaderlogoa09.jpg GRAPHIC 11495
3 qiagenfootera07.jpg GRAPHIC 7766
  Complete submission text file 0001015820-16-000045.txt   91746
Mailing Address SPOORSTRAAT 50 KJ VENLO P7 5911
Business Address SPOORSTRAAT 50 KJ VENLO P7 5911 31-77-320-8400
QIAGEN NV (Filer) CIK: 0001015820 (see all company filings)

EIN.: 000000000 | State of Incorp.: P7 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 000-28564 | Film No.: 161335068
SIC: 2836 Biological Products, (No Diagnostic Substances)